Mandate

Nordstjernan invests in Mama Mia

December 20, 2017 M&A

Vinge has advised Nordstjernan in conjunction with the acquisition of the majority of shares in Barnmorskegruppen MAMA MIA Aktiebolag (”Mama Mia”), as a supplementary acquisition to Lideta Hälsovård.

Mama Mia conducts prenatal and childcare services at seven units in Stockholm and Malmö, as well as primary care at two units in Stockholm under the trademark, To Care. The company has grown quickly over the last few years and during the last financial year its turnover was approximately MSEK 200 with approximately 170 employees.

Vinge’s team consisted of Johan Winnerblad, Kristina Ekberg, Samra Baytar, Josephine Andersson, Martin Boström, Frida Ställborn and Mikaela Lang.
 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024